SPDR S&P Biotech (NYSEARCA:XBI) saw unusually large options trading on Tuesday. Stock traders bought 2,063 call options on the stock. This represents an increase of 265% compared to the average volume of 565 call options.

SPDR S&P Biotech (NYSEARCA XBI) opened at 71.60 on Friday. The firm’s 50-day moving average price is $70.23 and its 200 day moving average price is $67.15. SPDR S&P Biotech has a 12-month low of $49.51 and a 12-month high of $73.08.

The company also recently declared a quarterly dividend, which will be paid on Monday, June 26th. Shareholders of record on Tuesday, June 20th will be paid a dividend of $0.1101 per share. This represents a $0.44 dividend on an annualized basis and a yield of 0.62%. This is a boost from SPDR S&P Biotech’s previous quarterly dividend of $0.02. The ex-dividend date of this dividend is Friday, June 16th.

TRADEMARK VIOLATION WARNING: This piece was originally published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another site, it was illegally copied and republished in violation of US & international copyright law. The legal version of this piece can be read at https://www.watchlistnews.com/spdr-sp-biotech-sees-unusually-high-options-volume-xbi-3/1371730.html.

About SPDR S&P Biotech

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with Analyst Ratings Network's FREE daily email newsletter.